Here, we systematically explored the effect of targeting G6PD on oxaliplatin efficacy in CRC in cells, cell line-based xenografts or PDX models with high expression of G6PD, suggesting this treatment approach could be used for CRC. The gene discussed is G6PD; the disease is colorectal carcinoma.